mixtures (30 μL) for monitoring sulfur transfer included 3 μM
SD, 9–120 μM ISCU2, buffer A, and either 0 or 9 μM
FXN. A similar experiment was performed in which FRDA FXN variants
N146K, Q148R, I154F, W155R, and R165C (each at 9 μM), which
were purified as previously described,24 (link),25 (link) were substituted
for native FXN. “Hot”
was prepared by adding 50 Ci/mmol [35S]cysteine (American
Radiolabeled Chemicals Inc.) to a 1 mM “cold” cysteine
stock solution. The hot
and reacted for 2 min at 37 °C, and the reactions were terminated
by centrifugation through a Micro Bio-Spin P-6 gel filtration column
(Bio-Rad). The spin column flow-through was combined with nonreducing
SDS–PAGE sample loading buffer and then loaded on a nonreducing
14% SDS–PAGE gel. The gel was dried on chromatography paper
in a gel-drying oven at 60 °C under vacuum before a 12 h exposure
to a phosphor screen. Incorporation of the 35S label was
visualized using a Phosphorimager (Typhoon Trio, GE Healthcare).